Pharmaceutical /
Life Science

GMP Vector Manufacturing Plant for Tissue Engineering, Courtesy of I’ROM Group Co., Ltd./ID Pharma Co., Ltd.

Chiyoda has been engaged in the field of engineering and construction of pharmaceutical facilities for more than 40 years, and has more than 400 project experiences.

In addition to conventional low molecular-weight pharmaceuticals production facility (finishing and API), Chiyoda has expanded the knowledge of biotechnology and cell technology, and is increasing the project experience for new fields such as high molecular-weight pharmaceuticals, medium molecular-weight pharmaceuticals, and regenerative medicines.

In addition to the engineering capabilities based on abundant project experience, Chiyoda has established in-house Research and Development laboratories for biotechnology and regenerative medicine in this April 2017, and thus Chiyoda offers high quality facility engineering/construction and other services including highly-advanced technologies.